Word: cholesterols
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Even when they were being treated by the same pool of physicians, whites were more likely than blacks to meet the commonly accepted cut-off point for long-term control over blood pressure (30 % v. 24%), over "bad" cholesterol (57% v. 45%), and over the blood-glucose measure, hemoglobin A1C (47% v. 39%). The researchers approached their data mindful of the need to ensure that any discrepancies were not simply the effects of what they term "sociodemographic factors": Comparing apples with apples - patients of the same gender, income-range and age - the white patients still fared far better...
...focus on the services that we think are most important. So instead of saying that we should focus on making sure every 25-year-old woman comes in for a preventive exam, what do we really want to make sure that woman has received? A pap smear, maybe a cholesterol screening - and similarly [come up with guidelines] for other age groups, and really focus on those key services we think are important...
...McCain regularly takes four medications: aspirin to prevent blood clots; Hydrochlorothiazide, for kidney stone prevention; Amiloride, to preserve potassium in the blood stream; and Simvastatin to lower his cholesterol. He also sometimes takes Ambien CR to help him sleep and Zyrtec, an antihistamine for nasal allergies...
...about commercialization. A pediatrician recently wrote an open letter on Salon.com taking issue with Lucas's newest fast food tie-ins, an Indy Whopper and a Snickers Adventure bar with coconut and chai. "Wouldn't Indy, now a senior citizen, have more than just a little bump in his cholesterol if he had scarfed down his namesake burger?" the doctor asks. "How could he be fit enough to chase down ancient relics while dodging boulders and outwitting Nazis...
Merck/Schering-Plough's one-minute ad for the cholesterol-lowering drug Vytorin is a standard example: it repeats the drug's benefits over and over, but squeezes in risk information only once and just after the halfway mark. You won't see it on TV anymore - the drug maker pulled the ad in January after releasing results of a two-year trial that showed Vytorin was no better than a cheaper generic statin drug at preventing heart disease - but you can watch our dissection of it below...